Your browser doesn't support javascript.
loading
An Oncolytic Virus Expressing IL15/IL15Rα Combined with Off-the-Shelf EGFR-CAR NK Cells Targets Glioblastoma.
Ma, Rui; Lu, Ting; Li, Zhenlong; Teng, Kun-Yu; Mansour, Anthony G; Yu, Melissa; Tian, Lei; Xu, Bo; Ma, Shoubao; Zhang, Jianying; Barr, Tasha; Peng, Yong; Caligiuri, Michael A; Yu, Jianhua.
Afiliação
  • Ma R; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, California.
  • Lu T; Laboratory of Molecular Oncology, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Chengdu, P.R. China.
  • Li Z; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, California.
  • Teng KY; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, California.
  • Mansour AG; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, California.
  • Yu M; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, California.
  • Tian L; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, California.
  • Xu B; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, California.
  • Ma S; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, California.
  • Zhang J; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, California.
  • Barr T; Department of Computational and Quantitative Medicine, City of Hope National Medical Center, Los Angeles, California.
  • Peng Y; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, California.
  • Caligiuri MA; Laboratory of Molecular Oncology, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Chengdu, P.R. China. mcaligiuri@coh.org jiayu@coh.org yongpeng@scu.edu.cn.
  • Yu J; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, California. mcaligiuri@coh.org jiayu@coh.org yongpeng@scu.edu.cn.
Cancer Res ; 81(13): 3635-3648, 2021 07 01.
Article em En | MEDLINE | ID: mdl-34006525
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Matadoras Naturais / Glioblastoma / Interleucina-15 / Vírus Oncolíticos / Subunidade alfa de Receptor de Interleucina-15 / Receptores de Antígenos Quiméricos Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Cancer Res Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Matadoras Naturais / Glioblastoma / Interleucina-15 / Vírus Oncolíticos / Subunidade alfa de Receptor de Interleucina-15 / Receptores de Antígenos Quiméricos Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Cancer Res Ano de publicação: 2021 Tipo de documento: Article